source
- UCB commits $2 billion to Candid's T cell engager program for autoimmune diseasesUCB, a long standing European pharmaceutical company, announced a $2 billion investment in Candid, a biotech focused on T cell engager therapies aimed at autoimmune conditions. The deal reflects U…
- Supreme Court reverses stay, allowing mail ordering of abortion pill mifepristoneThe U.S. Supreme Court issued a decision on Monday that restores the ability to order the abortion medication mifepristone by mail. This action overturns a stay that had been placed by a federal ap…